Clinical trial
A Study Evaluating the Pharmacokinetics of Dabigatran Etexilate in Adult Healthy Subjects, Elderly Healthy Subjects, and Elderly Patients With Atrial Fibrillation
NCT05715658 is registered in ClinicalTrials.gov with Dongyang Liu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study Evaluating the Pharmacokinetics of Dabigatran Etexilate in Adult Healthy Subjects, Elderly Healthy Subjects, and Elderly Patients With Atrial Fibrillation
- Lead sponsor
- Dongyang Liu
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 15, 2022
- Completion date
- July 30, 2023
- Enrollment
- 36 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
health, subjective, nonvalvular atrial fibrillation